Xue Y, Hou X, Zhong Y, Zhang Y, Du S, Kang D
Nat Commun. 2025; 16(1):2198.
PMID: 40038251
PMC: 11880362.
DOI: 10.1038/s41467-025-57149-2.
Chen Z, Xie F, Zhang H, Li D, Zhang S, Zhang M
Front Public Health. 2025; 13:1478627.
PMID: 39935878
PMC: 11811089.
DOI: 10.3389/fpubh.2025.1478627.
Awadalla M, AlRawi H, Henawi R, Barnawi F, Alkadi H, Alyami A
Front Immunol. 2025; 16:1526444.
PMID: 39911379
PMC: 11794813.
DOI: 10.3389/fimmu.2025.1526444.
Bazylewicz M, Zajkowska M, Gudowska-Sawczuk M, Kulakowski R, Mroczko J, Mirowska-Guzel D
Biomedicines. 2025; 13(1).
PMID: 39857737
PMC: 11763107.
DOI: 10.3390/biomedicines13010153.
Schwab J, Foglierini M, Pescosolido E, Pacheco I, Ruiz Buendia G, Madelon N
Commun Med (Lond). 2024; 4(1):254.
PMID: 39616213
PMC: 11608360.
DOI: 10.1038/s43856-024-00656-y.
Immunogenicity and Safety of Omicron-Containing Multivalent COVID-19 Vaccines in Unvaccinated and Previously Vaccinated Adults.
Hannawi S, Abuquta A, Eldin L, Hassan A, Alamadi A, Gao C
Vaccines (Basel). 2024; 12(10).
PMID: 39460276
PMC: 11510771.
DOI: 10.3390/vaccines12101109.
SARS-CoV-2 XBB.1.5 mRNA booster vaccination elicits limited mucosal immunity.
Lasrado N, Rowe M, McMahan K, Hachmann N, Miller J, Jacob-Dolan C
Sci Transl Med. 2024; 16(770):eadp8920.
PMID: 39441905
PMC: 11542980.
DOI: 10.1126/scitranslmed.adp8920.
COVID-19 Vaccination in Liver Cirrhosis: Safety and Immune and Clinical Responses.
Canha I, Silva M, Azevedo Silva M, Costa M, Saraiva R, Ruge A
GE Port J Gastroenterol. 2024; 31(5):325-337.
PMID: 39360169
PMC: 11444661.
DOI: 10.1159/000534740.
Feasibility and Effectiveness of Vaccines for COVID-19: An Umbrella Review.
SeyedAlinaghi S, Pashapouryeganeh A, Dehghani S, Mirzapour P, Abbaspour F, Afroughi F
Arch Acad Emerg Med. 2024; 13(1):e6.
PMID: 39318867
PMC: 11417638.
DOI: 10.22037/aaem.v12i1.2357.
Insights from an observational translational research program during the COVID-19 pandemic: Four years of experience.
Rowe M, Collier A, Barouch D
Vaccine. 2024; 42(24):126306.
PMID: 39241351
PMC: 11401756.
DOI: 10.1016/j.vaccine.2024.126306.
Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primates.
Gagne M, Flynn B, Andrew S, Marquez J, Flebbe D, Mychalowych A
Nat Immunol. 2024; 25(10):1913-1927.
PMID: 39227514
PMC: 11436372.
DOI: 10.1038/s41590-024-01951-5.
Ipsilateral or contralateral boosting of mice with mRNA vaccines confers equivalent immunity and protection against a SARS-CoV-2 Omicron strain.
Ying B, Liang C, Desai P, Scheaffer S, Elbashir S, Edwards D
J Virol. 2024; 98(9):e0057424.
PMID: 39194250
PMC: 11406931.
DOI: 10.1128/jvi.00574-24.
Comprehensive Review of COVID-19: Epidemiology, Pathogenesis, Advancement in Diagnostic and Detection Techniques, and Post-Pandemic Treatment Strategies.
Chung Y, Lam C, Tan P, Tsang H, Wong S
Int J Mol Sci. 2024; 25(15).
PMID: 39125722
PMC: 11312261.
DOI: 10.3390/ijms25158155.
Robust immunity conferred by combining COVID-19 vaccine platforms in older adults.
van de Sandt C, Kedzierska K
Nat Aging. 2024; 4(8):1036-1038.
PMID: 38997423
DOI: 10.1038/s43587-024-00668-2.
Neutralizing antibody responses assessment after vaccination in people living with HIV using a surrogate neutralization assay.
Batchi-Bouyou A, Djontu J, Ingoba L, Mougany J, Mouzinga F, Mbama Ntabi J
BMC Immunol. 2024; 25(1):43.
PMID: 38987686
PMC: 11234560.
DOI: 10.1186/s12865-024-00625-z.
Three SARS-CoV-2 spike protein variants delivered intranasally by measles and mumps vaccines are broadly protective.
Zhang Y, Chamblee M, Xu J, Qu P, Shamseldin M, Yoo S
Nat Commun. 2024; 15(1):5589.
PMID: 38961063
PMC: 11222507.
DOI: 10.1038/s41467-024-49443-2.
Age differentially impacts adaptive immune responses induced by adenoviral versus mRNA vaccines against COVID-19.
Dallan B, Proietto D, De Laurentis M, Gallerani E, Martino M, Ghisellini S
Nat Aging. 2024; 4(8):1121-1136.
PMID: 38918602
DOI: 10.1038/s43587-024-00644-w.
Analysis of Cell Immunity for Children Infected with SARS-CoV-2 and Those Vaccinated against SARS-CoV-2 Using T-SPOT.COVID.
Oishi T, Yasui Y, Kato A, Ogita S, Eitoku T, Enoki H
Microorganisms. 2024; 12(5).
PMID: 38792804
PMC: 11124318.
DOI: 10.3390/microorganisms12050975.
Antibody longevity and waning following COVID-19 vaccination in a 1-year longitudinal cohort in Bangladesh.
Haq M, Roy A, Ahmed R, Kuddusi R, Sinha M, Hossain M
Sci Rep. 2024; 14(1):11467.
PMID: 38769324
PMC: 11106241.
DOI: 10.1038/s41598-024-61922-6.
Baseline characteristics of SARS-CoV-2 vaccine non-responders in a large population-based sample.
Yaseen A, DeSantis S, Sabharwal R, Talebi Y, Swartz M, Zhang S
PLoS One. 2024; 19(5):e0303420.
PMID: 38739625
PMC: 11090326.
DOI: 10.1371/journal.pone.0303420.
